Literature DB >> 4347648

Failure of cytarabine in varicella-zoster infections.

C M Davis, J V VanDersarl, C A Coltman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4347648

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Letter: Intravenous cytarabine in treatment of herpes zoster in haematological malignancy.

Authors:  S Kernbaum
Journal:  Br Med J       Date:  1976-01-24

Review 2.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1974-08       Impact factor: 2.401

3.  The enigma of herpes stromal disease.

Authors:  J McGill
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

4.  In vitro susceptibility of varicella-zoster virus to acyclovir.

Authors:  K K Biron; G B Elion
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

5.  Topical acyclovir in herpes zoster ocular involvement.

Authors:  J McGill
Journal:  Br J Ophthalmol       Date:  1981-08       Impact factor: 4.638

6.  Assessment of cytosine arabinoside as an antiviral agent in humans.

Authors:  C B Lauter; E J Bailey; A M Lerner
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

7.  Enzymatic basis for the selective inhibition of varicella-zoster virus by 5-halogenated analogues of deoxycytidine.

Authors:  M J Dobersen; M Jerkofsky; S Greer
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

Review 8.  Antiviral therapy.

Authors:  H Stalder
Journal:  Yale J Biol Med       Date:  1977 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.